Article Information
History
- July 18, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Emily A. Bruce1,¶,#,*,
- Margaret G. Mills2,#,
- Reigran Sampoleo2,
- Garrett A. Perchetti2,
- Meei-Li Huang2,
- Hannah W. Despres3,
- David J. Shirley4,
- Keith R. Jerome2,5,
- Alexander L. Greninger2,5,* and
- Jason W. Botten1,3,*
- 1Division of Immunobiology, Department of Medicine, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington VT, 05405, USA
- 2Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle WA 98195, USA
- 3Department of Microbiology and Molecular Genetics, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington VT, 05405, USA
- 4Faraday, Inc. Data Science Department. Burlington VT, 05405, USA
- 5Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA 98109, USA
- ↵*Correspondence: Emily.bruce{at}med.uvm.edu (EAB), agrening{at}uw.edu (ALG), jbotten{at}uvm.edu (JWB)
↵# EAB and MGM contributed equally to this work.
Posted July 18, 2021.
Predicting Infectivity: Comparing Four PCR-based Assays to Detect Culturable SARS-CoV-2 in Clinical Samples
